#ASH24 #nonsense

@ash-hematology.bsky.social

Thank you #ASH24 for a fun meeting and all the education. Also, thank you for easy CME process:

Step ONE: Pay $30 before anything else. OK
Step TWO: Pick and EVALUATE EACH session you attended. Fine makes sense.
Step THREE: Write a statement

#ASH24
#BMTsm
Pierini -
1. Novel conditioning regimens: TMLI
2. Graft manipulation Treg/Tcon or a/b(-)
3. Donor selection: NK cell reactivity and others

#ASH24
Reducing post allo relapse - Vago
Knowledge of mechanism of relapse post allo is important to direct therapeutics

Generic HLA loss
Epigenetic loss of HLA II
Offending drugs and genotoxic/microbiotic

#BMTsm

#ASH24
#CeleBMTies

Dr. Steve Devine needs no introduction. One of the greatest BMT investigators of my time. Now starting and running transformative trials through the @nmdp-org.bsky.social

Dr. Logan's presence on #Bluesky should immediately attract whoever is still on the other platform.

#ASH24
#BestSlideSummaries
#WhatAreWeCallingThese skies? Posts? Blues?

#ASH24
#BMTsm
#CeleBMTies
#BMTmemories

Dr. Mukta Arora spotted at ASH. Seminal contributions to the field of GVHD.

#ASH24

Is it a bird? Is it a new CAR-T? Nope. Just good tacos.
Wish you all lines this long for your presentations!

#ASH24

Airport registration is a nice touch. No line.

Taxi.. different story. #carpool

Really enjoying Bluesky #bsky as I get ready to go to #ASH24
Feels like the old days with good science and nice people. Looking forward to seeing everyone there!

#BMTsm

MMF is not all good. In fact, might be pretty detrimental for engraftment in high doses (and RFS in some papers).

#ASH24
#BMTsm

ash.confex.com/ash/2024/web...

ash.confex.com/ash/2024/web...

GLP-2 agonist for treatment of aGVHD. 31 patients, mostly with G 3/4 GVHD. ORR ~50% with durable CRs of ~30%. 11 patients with G5 events - unrelated to study drug. Unmet need for non-immunosuppressive therapies
#ASH24
#BMTsm